Next Article in Journal
Socioeconomic Profile of Tourists with a Greater Circular Attitude and Behaviour in Hotels of a Sun and Beach Destination
Next Article in Special Issue
Effectiveness of a Novel HIV Self-Testing Service with Online Real-Time Counseling Support (HIVST-Online) in Increasing HIV Testing Rate and Repeated HIV Testing among Men Who Have Sex with Men in Hong Kong: Results of a Pilot Implementation Project
Previous Article in Journal
Environmental Policy Integration in the Energy Sector of China: The Roles of the Institutional Context
Previous Article in Special Issue
Characteristics of Mother–Daughter Relationships and Sexual Risk-Coping Consciousness among Japanese Female University Students
Review

Who Is Best to Test? A Systematic Review of Chlamydia Infections in Switzerland

1
Pharmaceutical Care Research Group, University of Basel, 4001 Basel, Switzerland
2
Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland
3
University of Basel, 4001 Basel, Switzerland
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2020, 17(24), 9389; https://doi.org/10.3390/ijerph17249389
Received: 19 October 2020 / Revised: 4 December 2020 / Accepted: 11 December 2020 / Published: 15 December 2020
(This article belongs to the Special Issue Sexually Transmitted Diseases: Diagnosis and Control)
In many countries, community pharmacies provide sexual-health-related services to limit the spread of sexually transmitted infections (STIs), including chlamydia testing. To identify suitable target groups for pharmacy-based chlamydia testing in Switzerland, we aimed to assess chlamydia prevalence, identify risk groups, and delineate screening strategies. We conducted a systematic literature search up to December 2019 in PubMed, EMBASE, and Web of Science, according to the PRISMA guidelines, using as keywords “chlamydia”, “screening”, and “Switzerland”. Two researchers screened the title, abstract, and full-text article and assessed the methodological quality. The literature search generated 108 hits, and nine studies were included. Chlamydia prevalence ranged between 0.8 and 12.8%. Most frequently affected were undocumented women undergoing voluntary termination of pregnancy (12.8%, 95% CI: 8.4–18.9), HIV-positive men who have sex with men (10.9%, 95% CI: 9.2–17.6), and adult offenders (6.5%, 95% CI: 3.2–9.0). Systematic screening was suggested for the first two risk groups and women suffering a miscarriage. To conclude, chlamydia infections are prevalent in Switzerland, but the identified risk groups are difficult to reach for a pharmacy-based testing service. More studies are needed to identify suitable target groups, including customers seeking sexual health services, particularly emergency contraception users who already receive counselling for STIs at community pharmacies. View Full-Text
Keywords: chlamydia; screening; pharmacy; Switzerland chlamydia; screening; pharmacy; Switzerland
Show Figures

Figure 1

MDPI and ACS Style

Haag, M.; Zemp, E.; Hersberger, K.E.; Arnet, I. Who Is Best to Test? A Systematic Review of Chlamydia Infections in Switzerland. Int. J. Environ. Res. Public Health 2020, 17, 9389. https://doi.org/10.3390/ijerph17249389

AMA Style

Haag M, Zemp E, Hersberger KE, Arnet I. Who Is Best to Test? A Systematic Review of Chlamydia Infections in Switzerland. International Journal of Environmental Research and Public Health. 2020; 17(24):9389. https://doi.org/10.3390/ijerph17249389

Chicago/Turabian Style

Haag, Melanie, Elisabeth Zemp, Kurt E. Hersberger, and Isabelle Arnet. 2020. "Who Is Best to Test? A Systematic Review of Chlamydia Infections in Switzerland" International Journal of Environmental Research and Public Health 17, no. 24: 9389. https://doi.org/10.3390/ijerph17249389

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop